Drug Study (Mucosulvan, Verorab, Tetanus Toxoid)

"Tetanus Toxoid" GENERIC NAME: Anti-tetanus serum BRAND NAME: Tetanus Toxoid GENERAL CLASSIFICATION: EPI vaccine, Anti-tetanus INDICATION: Tetanus Toxoid is indicated for booster injection only for persons 7 yrs of age and older against tetanus. Primary immunization schedule for children under 7 yrs of age should consist of five doses of vaccine containing tetanus toxoid. Tetanus Toxoid is not to be used for treatment of tetanus infection. As with any vaccine, vaccination with tetanus toxoid may not protect 100% of susceptible individuals. DOSAGES: After the initial immunization series is completed, a booster dose of 0.5mL of tetanus toxoid should be given intramuscularly every 10 yrs to maintain adequate immunity. SIDE EFFECT/ ADVERSE REACTION: o Body System as a whole: Redness, warmth, edema, induration with or without tenderness as well as urticaria, and rash. Malaise, transient fever, pain, hypotension, nausea, and arthralgia NURSING CONSIDERATION: Shake well the vial before withdrawing each dose Special care should be taken to ensure that the injection does not enter the blood vessel For Nursing Mothers: Tetanus Toxoid does not affect the safety of mothers who are breastfeeding or their infants. Breastfeeding does not adversely affect immune response and is not a contraindication for vaccination For Pediatric Use: Safety and effectiveness of tetanus toxoid in infants below the age of 6 weeks has not been established. However, this vaccine is not indicated for children under 7 yrs of age. For Geriatric Use: Tetanus Toxoid should only be used in geriatric patients known to have received a primary series of tetanus-containing vaccine, since many such as persons have no prior immunity.